Search
for
Sort by
Research 241–270 of 1000+
- Inhibitors of 5α-reductase-related side effects in patients seeking medical care for sexual dysfunction.
- The Use of Stromal Vascular Fraction in the Treatment of Male Sexual Dysfunction: A Review of Preclinical and Clinical Studies
- Safety and efficacy of transdermal testosterone for treatment of hypoactive sexual desire disorder
- Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs
- Adverse Reactions to Oral Retinoids An Update
- Female sexuality and common sexual dysfunctions: evaluation and management in a primary care setting
- Sexual dimorphism of COVID-19 inspires drug repositioning and host-targeting immunotherapy for viral pneumonia
- Severe cutaneous adverse reactions to drugs
- Adverse health effects of androgen use
- Adverse Drug Reactions in HIV/AIDS Patients on Highly Active Antiretro Viral Therapy: A Review of Prevalence
- Androgens and Female Sexual Function and Dysfunction—Findings From the Fourth International Consultation of Sexual Medicine
- Is polycystic ovary syndrome a sexual conflict? A review
- The Neurobiology of Sexual Function
- REPORTS: Summary of the Recommendations on Sexual Dysfunctions in Women
- Summary of the Recommendations on Sexual Dysfunctions in Women
- Genetic Defects of Female Sexual Differentiation
- Clinical Evidence of Increase in Hair Growth and Decrease in Hair Loss without Adverse Reactions Promoted by the Commercial Lotion ECOHAIR®
- Association Between Androgenetic Alopecia Severity and Sexual Dysfunction in Male and Female Patients Attending a Dermatology Clinic: An Exploratory Cross-Sectional Study
- The hydroxypropyl‐β‐cyclodextrin‐minoxidil inclusion complex improves the cardiovascular and proliferative adverse effects of minoxidil in male rats: Implications in the treatment of alopecia
- Impact of ustekinumab on quality of life and sexual difficulties associated with psoriasis: Results from phase III clinical trials
- 1. Medical Practice; Therapy; Adverse Reactions
- 105 Spironolactone May be a Cause of Hormonally Associated Vestibulodynia and Female Genital Arousal Disorder
- Effect of dutasteride 0.5 mg/d in men with androgenetic alopecia recalcitrant to finasteride
- 133 Female Post-Finasteride Syndrome: It’s Not Just A Man’s World
- 5-α-Reductase inhibitors for prostate cancer chemoprevention: an updated Cochrane systematic review
- Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7
- Post-Finasteride Syndrome: An Induced Delusional Disorder with the Potential of a Mass Psychogenic Illness?
- Expanding the therapeutic landscape of minoxidil for androgenetic alopecia: topical, oral and sublingual formulations
- Finasteride and Dutasteride in the Treatment of Androgenetic Alopecia: Risk or Benefit?
- Gender-Affirming Hormone Therapy for Transgender Females